Health
Wolters Kluwer Unveils Ovid Synthesis Expert AI to Enhance Healthcare
Wolters Kluwer Health has launched new artificial intelligence features in its Ovid Synthesis platform, aimed at supporting nursing and quality improvement leaders, practitioners, and researchers. The introduction of the Ovid Synthesis Expert AI is designed to enhance the quality, speed, and overall impact of improvement projects in healthcare settings.
The new AI capabilities, now available as an optional add-on to the Ovid Synthesis platform, streamline various project tasks traditionally performed manually. This development comes in response to the increasing demand for healthcare systems to deliver measurable improvements with limited resources. According to Rafael Sidi, Senior Vice President and General Manager of Health Research at Wolters Kluwer Health, “Ovid Synthesis Expert AI is designed to eliminate the friction points that slow down improvement initiatives.”
One of the primary goals of Ovid Synthesis Expert AI is to help healthcare professionals reclaim time for patient care by addressing common challenges that hinder quality improvement and evidence-based practice (EBP) projects. These include the lengthy critical appraisal process, delays in mentor feedback, and the extensive manual effort required for research dissemination.
Key Features of Ovid Synthesis Expert AI
The platform offers several innovative features that enhance the efficiency of healthcare professionals, enabling them to scale their impact regardless of their experience or location.
1. **Critical Appraisal**: The AI generates summaries linked to sources, allowing teams to assess literature efficiently while ensuring rigor through easy source verification.
2. **Clinical Question Feedback**: The AI provides real-time guidance for PICO(T) questions, keeping projects focused and well-defined, which reduces the reliance on overburdened mentors.
3. **Dissemination**: The AI automatically converts project results into multiple publication-ready formats, including conference abstracts, manuscript drafts, and newsletter content. This feature significantly accelerates knowledge sharing.
These enhancements aim to improve clinician satisfaction and patient outcomes by streamlining workflows, facilitating collaboration, and providing easier access to reliable evidence. Healthcare organizations utilize the Ovid Synthesis platform to demonstrate return on investment (ROI) from quality improvement initiatives, justifying ongoing investment in evidence-based practices.
Guided Development and Future Implications
The development of Ovid Synthesis Expert AI was informed by feedback from medical librarians and clinicians who identified persistent challenges in implementing EBP, QI, and research projects. Wolters Kluwer applied its extensive experience in artificial intelligence to create a solution that not only enhances workforce efficiency but also maintains academic rigor.
By reducing variability in research proficiency and lowering barriers to scholarly dissemination, Ovid Synthesis Expert AI supports both project-level execution and broader institutional objectives for continuous learning and improvement. The platform is powered by the Wolters Kluwer Expert AI framework, a trusted technology designed to assist healthcare professionals in making informed decisions based on verified, evidence-based content.
As healthcare systems continue to face increasing pressure to improve outcomes with limited resources, the introduction of Ovid Synthesis Expert AI represents a significant advancement in the field of healthcare quality improvement.
-
Science1 week agoInventor Achieves Breakthrough with 2 Billion FPS Laser Video
-
Top Stories2 weeks agoCharlie Sheen’s New Romance: ‘Glowing’ with Younger Partner
-
Entertainment2 weeks agoDua Lipa Aces GCSE Spanish, Sparks Super Bowl Buzz with Fans
-
Business2 weeks agoTyler Technologies Set to Reveal Q3 Earnings on October 22
-
Entertainment2 weeks agoMother Fights to Reunite with Children After Kidnapping in New Drama
-
World2 weeks agoR&B Icon D’Angelo Dies at 51, Leaving Lasting Legacy
-
Science2 weeks agoNorth Carolina’s Biotech Boom: Billions Invested in Manufacturing
-
Health2 weeks agoCurium Group, PeptiDream, and PDRadiopharma Launch Key Cancer Trial
-
Health2 weeks agoNorth Carolina’s Biotech Boom: Billions in New Investments
-
Entertainment2 weeks agoRed Sox’s Bregman to Become Free Agent; Tigers Commit to Skubal
-
Health2 weeks agoCommunity Unites for 7th Annual Into the Light Walk for Mental Health
-
Top Stories2 weeks agoDisney+ Launches Chilling Classic ‘Something Wicked’ Just in Time for October
